Welcome to the Hardcore Husky Forums. Folks who are well-known in Cyberland and not that dumb.
Options
It’s not over for Rolo
doogie
Member Posts: 15,072
WSU is a research University with a med school, right? Shouldn’t be hard at all for WSU to get Rolo into the trial
Drug firm AstraZeneca on Friday announced positive results from a trial of a treatment for COVID-19 symptoms.
The drug, made from a combination of two antibodies, was initially developed as a treatment for those who had already been exposed to the disease.
A new trial of 5,197 participants who had not been exposed showed a 77-percent reduced risk of developing symptomatic disease, with no severe cases recorded, Astra said in a statement.
A previous trial of the AZD7442 drug had shown it only reduced the risk of developing symptoms by 33 percent, which it concluded in June was not statistically significant.
The data show that one dose could "quickly and effectively prevent symptomatic COVID-19", said Myron Levin, principal trial investigator.
"With these exciting results, AZD7442 could be an important tool in our arsenal to help people who may need more than a vaccine to return to their normal lives."
It is hoped that the drug could be used alongside vaccines for those who need more protection, affording up to 12 months of defence.
https://medicalxpress.com/news/2021-08-astrazeneca-hails-trial-results-covid.html
Drug firm AstraZeneca on Friday announced positive results from a trial of a treatment for COVID-19 symptoms.
The drug, made from a combination of two antibodies, was initially developed as a treatment for those who had already been exposed to the disease.
A new trial of 5,197 participants who had not been exposed showed a 77-percent reduced risk of developing symptomatic disease, with no severe cases recorded, Astra said in a statement.
A previous trial of the AZD7442 drug had shown it only reduced the risk of developing symptoms by 33 percent, which it concluded in June was not statistically significant.
The data show that one dose could "quickly and effectively prevent symptomatic COVID-19", said Myron Levin, principal trial investigator.
"With these exciting results, AZD7442 could be an important tool in our arsenal to help people who may need more than a vaccine to return to their normal lives."
It is hoped that the drug could be used alongside vaccines for those who need more protection, affording up to 12 months of defence.
https://medicalxpress.com/news/2021-08-astrazeneca-hails-trial-results-covid.html
Comments
Then let the games begin.
It’s not over for Rolo since now he has “science” on his side.
Feel better, now?
You can see the 33 or the 666 in nearly everything they do. A previous trial of the AZD7442 drug had shown it only reduced the risk of developing symptoms by 33 percent. 66.6% efficacy, wow.
Oh look, they just made another mistake on live television... or did they? Was it intentional?
They were running adrenochrome trafficking operations in Afghanistan and were evicted and humiliated, like they will be evicted from Taiwan and Ukraine.